Filing Flows › CervoMed (CRVO) › Q4 2025 › vs Q3 2025
CervoMed (CRVO) Q4 2025 vs Q3 2025 (quarter over quarter)
CervoMed's revenue fell $314K (-97%) from $323K in Q3 2025 to $9K in Q4 2025.
CervoMed, Q4 2025: revenue $9K (-100% year over year), net loss $8.1M, operating cash flow −$6.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q4 2025 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $9K | $323K | −$314K | -97% |
| Other income, net | $244K | $318K | −$73K | -23% |
| Net loss | $8.1M | $7.7M | $361K | +5% |
| Costs & expenses | $8.3M | $8.4M | −$27K | -0.3% |
| Operating costs | $8.3M | $8.4M | −$27K | -0.3% |
| Research & development | $5.8M | $6.0M | −$210K | -3% |
| General & admin | $2.5M | $2.3M | $184K | +8% |
| Operating cash sources | $8.1M | $7.7M | $361K | +5% |
| Share-based compensation | $299K | $292K | $7K | +2% |
| Working capital & other | $1.2M | $970K | $243K | +25% |
| Cash used in operations | $6.6M | $6.5M | $110K | +2% |
| Net loss absorbed | $8.1M | $7.7M | $361K | +5% |
Questions
How much did CervoMed's revenue grow quarter over quarter in Q4 2025?
CervoMed's revenue fell $314K (-97%) from $323K in Q3 2025 to $9K in Q4 2025.